Clinical Trial Update: Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE) [Phase 4]

View source ↗

Summary

Phase 4 trial for HCV infection titled ECLIPSE has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: HCV Infection | Phase 4 | Status: WITHDRAWN